Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.

Montgomery, R Bruce

Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer. [electronic resource] - Cancer Sep 2007 - 996-1002 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0008-543X

10.1002/cncr.22917 doi


Adenocarcinoma--blood
Administration, Oral
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Diarrhea--chemically induced
Diethylstilbestrol--administration & dosage
Drug Administration Schedule
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasm Metastasis
Paclitaxel--administration & dosage
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Treatment Outcome
Tubulin Modulators--administration & dosage
Venous Thrombosis--chemically induced